THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI): Relationship to Hemostatic Alteration in Patients with β-Thalassemia

Author: Mokhtar Galila M.   Matter Randa M.   Shawki H.   Abdel Aziz Manal M.  

Publisher: Informa Healthcare

ISSN: 1521-0669

Source: Pediatric Hematology and Oncology, Vol.27, Iss.5, 2010-07, pp. : 363-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content